|
Mankind Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
99751.34 Cr.
|
P/BV
|
9.44
|
Book Value (Rs.)
|
255.98
|
|
52 Week High/Low (Rs.)
|
3055/2115
|
FV/ML
|
1/1
|
P/E(X)
|
50.10
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
48.24
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 12207.44 | 10333.63 | 8742.85 | 7781.56 | 6214.43 |
| Other Operating Revenues | 0.00 | 1.15 | 6.58 | 0.00 | 0.00 |
| Total Operating Revenues | 12207.44 | 10334.77 | 8749.43 | 7781.56 | 6214.43 |
| | | | | | |
| Other Income | 536.79 | 280.86 | 128.57 | 196.03 | 170.95 |
| Total Revenue | 12744.23 | 10615.63 | 8878.00 | 7977.58 | 6385.38 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 2016.35 | 1853.52 | 1813.66 | 2057.56 | 1373.18 |
| Purchase Of Stock-In Trade | 1655.69 | 1409.85 | 809.24 | 813.75 | 654.83 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -183.00 | -53.67 | 290.74 | -449.59 | -247.40 |
| Employee Benefit Expenses | 2692.37 | 2274.73 | 1918.47 | 1620.59 | 1415.78 |
| Finance Costs | 429.41 | 33.53 | 44.47 | 58.61 | 20.15 |
| Provisions And Contingencies | 0.00 | 0.00 | 0.00 | 0.00 | 17.71 |
| Depreciation And Amortisation Expenses | 621.22 | 398.25 | 325.92 | 166.62 | 118.97 |
| Other Expenses | 3008.10 | 2315.28 | 2016.68 | 1749.88 | 1352.23 |
| Total Expenses | 10240.14 | 8231.49 | 7219.18 | 6017.43 | 4705.45 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2504.09 | 2384.14 | 1658.81 | 1960.15 | 1679.93 |
| | | | | | |
| Profit/Loss Before Tax | 2504.09 | 2384.14 | 1658.81 | 1960.15 | 1679.93 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 596.04 | 492.58 | 327.56 | 469.03 | 396.17 |
| Deferred Tax | -86.30 | -35.00 | 34.01 | 52.61 | 2.41 |
| Total Tax Expenses | 509.74 | 457.59 | 361.56 | 521.64 | 398.58 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1994.35 | 1926.56 | 1297.25 | 1438.51 | 1281.36 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1994.35 | 1926.56 | 1297.25 | 1438.51 | 1281.36 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 8.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses Discontinuing Operations | 3.92 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit/Loss From Discontinuing Operations | 4.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss For The Period | 1998.88 | 1926.56 | 1297.25 | 1438.51 | 1281.36 |
| | | | | | |
| Minority Interest | -20.16 | -28.88 | -27.82 | -19.48 | -27.61 |
| Share Of Profit/Loss Of Associates | 12.24 | 15.21 | 12.42 | 14.45 | 11.68 |
| Consolidated Profit/Loss After MI And Associates | 1990.96 | 1912.90 | 1281.86 | 1433.48 | 1265.43 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 49.28 | 47.75 | 32.00 | 35.78 | 31.59 |
| Diluted EPS (Rs.) | 49.20 | 47.68 | 32.00 | 35.78 | 31.59 |
